Acacia Research (NASDAQ:ACTG – Get Free Report) is anticipated to release its Q2 2026 results before the market opens on Wednesday, August 5th. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $49.50 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Wednesday, August 5, 2026 at 8:00 AM ET.
Acacia Research (NASDAQ:ACTG – Get Free Report) last released its earnings results on Thursday, May 7th. The business services provider reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.02. The firm had revenue of $54.24 million for the quarter, compared to analysts’ expectations of $50.00 million. Acacia Research had a negative return on equity of 2.81% and a negative net margin of 8.53%.During the same quarter in the previous year, the business posted $0.25 EPS.
Acacia Research Price Performance
Shares of ACTG opened at $4.43 on Monday. The stock has a market capitalization of $427.89 million, a P/E ratio of -24.61 and a beta of 0.45. Acacia Research has a twelve month low of $3.12 and a twelve month high of $5.27. The company has a 50 day moving average of $4.61 and a 200-day moving average of $4.54. The company has a quick ratio of 8.09, a current ratio of 8.56 and a debt-to-equity ratio of 0.10.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on ACTG
Institutional Trading of Acacia Research
Several institutional investors and hedge funds have recently bought and sold shares of ACTG. Invesco Ltd. boosted its position in Acacia Research by 4.4% during the fourth quarter. Invesco Ltd. now owns 77,143 shares of the business services provider’s stock valued at $289,000 after purchasing an additional 3,252 shares during the last quarter. NewEdge Advisors LLC acquired a new position in shares of Acacia Research during the 4th quarter worth approximately $123,000. Empowered Funds LLC raised its stake in shares of Acacia Research by 11.3% during the 4th quarter. Empowered Funds LLC now owns 244,586 shares of the business services provider’s stock worth $915,000 after purchasing an additional 24,752 shares in the last quarter. Occudo Quantitative Strategies LP bought a new stake in shares of Acacia Research during the 4th quarter worth approximately $49,000. Finally, Bridgeway Capital Management LLC raised its stake in shares of Acacia Research by 65.4% during the 4th quarter. Bridgeway Capital Management LLC now owns 441,886 shares of the business services provider’s stock worth $1,653,000 after purchasing an additional 174,752 shares in the last quarter. Institutional investors own 86.69% of the company’s stock.
Acacia Research Company Profile
Acacia Research Corporation is a publicly traded patent licensing company based in New York City. The firm specializes in acquiring patented technologies through a network of wholly owned subsidiaries and seeking licensing agreements or settlements with companies that utilize those technologies. Since its founding in 1993, Acacia has built a business model centered on identifying innovative inventions and monetizing them through patent enforcement and strategic partnerships.
The company’s activities span a broad range of technology sectors, including life sciences, medical devices, software, telecommunications and consumer electronics.
Read More
- Five stocks we like better than Acacia Research
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Receive News & Ratings for Acacia Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acacia Research and related companies with MarketBeat.com's FREE daily email newsletter.
